000 01115 a2200313 4500
005 20250513092452.0
264 0 _c19960819
008 199608s 0 0 eng d
022 _a0022-3549
024 7 _a10.1021/js950141c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, D D
245 0 0 _aTransdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation.
_h[electronic resource]
260 _bJournal of pharmaceutical sciences
_cFeb 1996
300 _a214-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
_xchemistry
650 0 4 _aDidanosine
_xchemistry
650 0 4 _aDrug Delivery Systems
650 0 4 _aFemale
650 0 4 _aRats
650 0 4 _aSkin
_xdrug effects
650 0 4 _aZalcitabine
_xchemistry
650 0 4 _aZidovudine
_xchemistry
700 1 _aChien, Y W
773 0 _tJournal of pharmaceutical sciences
_gvol. 85
_gno. 2
_gp. 214-9
856 4 0 _uhttps://doi.org/10.1021/js950141c
_zAvailable from publisher's website
999 _c8681278
_d8681278